One U.S. biotech company is celebrating Independence Day weekend with a fresh $1 billion in cash from a corporate partner, which it was able to secure without giving up its […]
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Forbes Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngForbes Health2015-07-03 09:30:002015-07-08 14:50:55What You May Have Missed In Biotech: Celgene’s $1B Bet On Cancer Immunotherapy, And A New CF Drug